Therapeutic Intent in the Conduct of Phase I Antineoplastic Drug Trials

Publisher： Karger

E-ISSN： 1423-0232|76|3|149-150

ISSN： 0030-2414

Source： Oncology, Vol.76, Iss.3, 2009-01, pp. : 149-150

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Patient Expectations of Benefit from Phase I Clinical Trials: Linguistic Considerations in Diagnosing a Therapeutic Misconception

By Weinfurt K.P.  

Theoretical Medicine, Vol. 24, Iss. 4, 2003-01 ,pp. : 329-344

Springer Publishing Company

Access to resources Recommend Favorite

Parallel Conduction of the Phase I Preventive and Therapeutic Trials Based on the Tat Vaccine Candidate

By  

Reviews on Recent Clinical Trials, Vol. 4, Iss. 3, 2009-09 ,pp. : 195-204

Bentham Science Publishers

Access to resources Recommend Favorite

Assessing the quality of life in phase I and II anti-cancer drug trials: interviews versus questionnaires

By Cox K.  

Social Science and Medicine, Vol. 58, Iss. 3, 2004-02 ,pp. : 661-661

Elsevier

Access to resources Recommend Favorite

The Current State of Therapeutic Drug Trials in Pregnancy

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 92, Iss. 2, 2012-08 ,pp. : 149-150

John Wiley & Sons Inc

Access to resources Recommend Favorite

Monitoring late-onset toxicities in phase I trials using predicted risks

By Bekele B. Nebiyou   Ji Yuan   Shen Yu   Thall Peter F.  

Biostatistics, Vol. 9, Iss. 3, 2008-07 ,pp. : 442-457

Oxford University Press

Access to resources Recommend Favorite